Charles Schwab Investment Management Inc. Has $1.95 Million Position in Definitive Healthcare Corp. (NASDAQ:DH)

Charles Schwab Investment Management Inc. lifted its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 5.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 436,132 shares of the company’s stock after purchasing an additional 23,706 shares during the period. Charles Schwab Investment Management Inc. owned 0.37% of Definitive Healthcare worth $1,950,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. The Manufacturers Life Insurance Company boosted its holdings in Definitive Healthcare by 17.0% in the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock valued at $125,000 after acquiring an additional 3,332 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of Definitive Healthcare by 10.8% in the 2nd quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock valued at $218,000 after purchasing an additional 3,874 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Definitive Healthcare by 31.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after buying an additional 5,083 shares during the period. Victory Capital Management Inc. raised its stake in shares of Definitive Healthcare by 1.9% during the second quarter. Victory Capital Management Inc. now owns 509,009 shares of the company’s stock worth $2,779,000 after buying an additional 9,316 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in Definitive Healthcare by 50.5% in the second quarter. Renaissance Technologies LLC now owns 28,900 shares of the company’s stock valued at $158,000 after buying an additional 9,700 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on DH shares. BTIG Research assumed coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $4.46 on Tuesday. The stock has a market cap of $515.23 million, a PE ratio of -1.44, a P/E/G ratio of 3.29 and a beta of 1.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a 50-day moving average of $4.41 and a 200-day moving average of $4.71. Definitive Healthcare Corp. has a 52-week low of $3.19 and a 52-week high of $10.62.

Insiders Place Their Bets

In other news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 14.84% of the company’s stock.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.